Cayman Chemical, Curapath Join Forces to Expand Access to PEG-Free Shielding Lipids for LNPs
Cayman Chemical and Curapath have partnered to make PEG-free shielding lipids available to researchers advancing LNPs for non-viral drug delivery, gene therapy, mRNA vaccines, and biologic therapies.
Cayman Chemical | 04/09/2025 | By Mrinmoy Dey | 220
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy